REFERENCES
- Aufiero A., Sturani C., Zamon P. (1997) J. Chemotherapy, 9. 213–219.
- Burwen D.R., Banerjee S.N., Gaynes R.P. (1994) J. Infect. Dis., 170, 1622–1625.
- Barradell L.B., Bryson H.M. (1994) Drug. 47. 471–505.
- Hancock R.E.W., Bellido F. (1996) J. Chemotherapy. 8, S31–S36.
- Jarlier V. (1985) In: L'Antibiogramme. (P. Courvalin. Eds) MPC—VIDEOM, Paris. 87–101.
- Livermore D.M. (1995) Clin Microbiol. Rev., 8, 557–584.
- Liu P.Y.F., Deniz G., Lucinda M.C.H., Livermore D.M. (1992) J. Antimicrob. Chemother., 30, 429–447.
- National Committee of Clinical Laboratory Standarts. (1997) Performance standards for antimicrobial disk susceptibility tests. M2-A6. NCCLS, Villanova. Pa.
- National Committee of Clinical Laboratory Standarts. (1997) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M7-A4. NCCLS. Villanova. Pa.
- Pitout J.D.D., Moland E.S., Sanders C.C., Thomson K.S. (1997) Antimocrob. Agents Chemother., 41, 35–39.
- Sanders C.C. Sanders W.E. (1979) Antimicrob. Agents Chemother., 15, 792–797.
- Sanders C.C. (1993) Clin. Infect. Dis., 17, 369–379.
- Sanders C.C., Sanders W.E. (1992) Clin. Infect. Dis., 15, 824–839.
- Sofianou D., Tsoulfa S., Kontodimou L., Malaka E. (1997) J. Chemotherapy, 9, 341–347.
- Sanders W.E., Tenney J.H., Kessler R.E. (1996) Clin. Infect Dis., 23, 454–461.
- Wynd M.A., Paladino J.A. (1996) Ann. Pharmacother., 30, 1414–1424.
- Yao J.D.C. (1995) In: Manual for clinical microbiology. (P.R. Murray et al. Eds.). ASM Press, Washington, p.1285.